PML and acute myeloid leukemia: Next, the correlation between RHOBTB2 expression and clinical features, such as age, gender, FLT3 mutation, PML/RAR-fusion, and RAS activation status in AML patients, was analyzed through UALCAN (Figure 4B–4F).